Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis

  • Burkard T
  • Herrero San Juan M
  • Dreis C
  • et al.
N/ACitations
Citations of this article
8Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

BackgroundCytotoxic T lymphocytes take on a leading role in many immune-related diseases. They function as key effector immune cells fighting cancer cells, but they are also considerably involved in autoimmune diseases. Common to both situations, CD8(+) T cells need to adapt their metabolism and effector function to the harsh and nutrient-deprived conditions of the disease-associated microenvironment. MethodsWe used an in vitro starvation as well as rapamycin treatment protocol mimicking nutrient deprivation to generate CD8(Low) versus CD8(High) T cells and performed FACS-Sorting followed by transcriptomic profiling of the cytotoxic T cell subsets. Prominent markers identified in the CD8(Low) versus the CD8(High) T cells were then used to investigate the presence of these cell subsets in immune-related human diseases. Employing cancer tissue microarrays and PhenOptics multispectral imaging as well as flow cytometry, we studied these CD8(+) T cell subsets in cancer and relapsing-remitting multiple sclerosis patients. ResultsStarvation induced a decreased expression of CD8, yielding a CD8(Low) T cell subpopulation with an altered transcriptomic signature and reduced effector function. CD8(Low) T cell showed enhanced ST2L and IL6ST (CD130) expression compared to CD8(High) T cells which expressed elevated KLRD1 (CD94) and granzyme B levels within the tumour microenvironment (TME). Spatial analysis revealed the presence of CD8(High) T cells in close proximity to tumour cells, while the CD8(Low) T cells resided at the tumour boundaries. Importantly, the number of tumour-infiltrating CD8(Low) T lymphocytes correlated with a poor prognosis as well as with enhanced cancer progression in human mammary carcinoma. We also found a reduced frequency of CD8(Low) T lymphocytes in a cohort of relapse (disease active) multiple sclerosis patients compared to healthy subjects during immune cell starvation in vitro. ConclusionsIn summary, our data show that functionally distinct cytotoxic T lymphocytes can be identified based on their expression of CD8. Indicating a more general role in CD8 T cell immunity, these cells may play opposing roles in the TME, and also in the pathophysiology of autoimmune diseases such as multiple sclerosis.

Cite

CITATION STYLE

APA

Burkard, T., Herrero San Juan, M., Dreis, C., Kiprina, A., Namgaladze, D., Siebenbrodt, K., … Radeke, H. H. (2022). Differential expression of CD8 defines phenotypically distinct cytotoxic T cells in cancer and multiple sclerosis. Clinical and Translational Medicine, 12(12). https://doi.org/10.1002/ctm2.1068

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free